XML Feed for RxPG News   Add RxPG News Headlines to My Yahoo!   Javascript Syndication for RxPG News

Research Health World General
 
  Home
 
 Latest Research
 Cancer
 Psychiatry
  Depression
  Neuropsychiatry
  Personality Disorders
  Bulimia
  Anxiety
  Substance Abuse
   Alcohol
   Smoking
   Amphetamine
   Opiates
   Cannabis
   Cocaine
  Suicide
  CFS
  Psychoses
  Child Psychiatry
  Learning-Disabilities
  Psychology
  Forensic Psychiatry
  Mood Disorders
  Sleep Disorders
  Peri-Natal Psychiatry
  Psychotherapy
  Anorexia Nervosa
 Genetics
 Surgery
 Aging
 Ophthalmology
 Gynaecology
 Neurosciences
 Pharmacology
 Cardiology
 Obstetrics
 Infectious Diseases
 Respiratory Medicine
 Pathology
 Endocrinology
 Immunology
 Nephrology
 Gastroenterology
 Biotechnology
 Radiology
 Dermatology
 Microbiology
 Haematology
 Dental
 ENT
 Environment
 Embryology
 Orthopedics
 Metabolism
 Anaethesia
 Paediatrics
 Public Health
 Urology
 Musculoskeletal
 Clinical Trials
 Physiology
 Biochemistry
 Cytology
 Traumatology
 Rheumatology
 
 Medical News
 Health
 Opinion
 Healthcare
 Professionals
 Launch
 Awards & Prizes
 
 Careers
 Medical
 Nursing
 Dental
 
 Special Topics
 Euthanasia
 Ethics
 Evolution
 Odd Medical News
 Feature
 
 World News
 Tsunami
 Epidemics
 Climate
 Business
Search

Last Updated: Aug 19th, 2006 - 22:18:38

Cannabis Channel
subscribe to Cannabis newsletter

Latest Research : Psychiatry : Substance Abuse : Cannabis

   DISCUSS   |   EMAIL   |   PRINT
Call for public health campaign on cannabis
Sep 28, 2005, 07:51, Reviewed by: Dr.

�Cannabis is still seen as a risk-free drug despite mounting evidence that it can lead to serious mental health problems, particularly amongst young teenagers, people with a family history of severe mental illness and in long-term users.�

 
The mental healthy charity Rethink on September 23 gave evidence to the Advisory Council on the Mis-use of Drugs, which is considering the classification of cannabis at the request of the Home Secretary and called for a long-term, properly funded public health campaign highlighting the mental health dangers of using cannabis.

It warned the committee that it would be a waste of money to reverse its decision taken 18 months ago to reclassify cannabis from a Class B to Class C drug and would not deter people from using it.

Instead, the charity called for the money to be spent on a massive public education campaign to inform users and potential users of the well-founded mental health dangers of using cannabis at a young age and over a long period of time.

Rethink chief executive Cliff Prior told the committee: �Cannabis is still seen as a risk-free drug despite mounting evidence that it can lead to serious mental health problems, particularly amongst young teenagers, people with a family history of severe mental illness and in long-term users.�

Rethink told the committee that other countries had woken up to the dangers and invested heavily in public health campaigns, despite far lower rates of usage than Britain .

�The government has a responsibility to inform people of the real risks and not hide behind a knee-jerk criminal justice response to what is a mounting health crisis,� said Mr Prior.

The committee heard from one service user about his experience of using cannabis and developing schizophrenia and was presented with testimony from other service users and family members about the impact cannabis had on their lives.
 

- Rethink. Registered charity number 271028
 

Rethink's evidence to the Advisory Council on the Mis-use of Drugs (Word, 237kB)

 
Subscribe to Cannabis Newsletter
E-mail Address:

 

About Rethink severe mental illness
Rethink is a campaigning membership charity involving people with severe mental illness and carers, with a network of mutual support groups around the country. Rethink is also the largest voluntary sector service provider in mental health, helping 7500 people each day.


Related Cannabis News

Increase in psychotic symptoms predicts relapse to cannabis use
New PET Radiotracer to Visualize Cannabinoid Receptors Developed
Cannabis Based Medicine to be Supplied in Spain
Call for public health campaign on cannabis
Canada approved Cannabis extract Based Drug


For any corrections of factual information, to contact the editors or to send any medical news or health news press releases, use feedback form

Top of Page

 

© Copyright 2004 onwards by RxPG Medical Solutions Private Limited
Contact Us